Can Vasomedical’s EECP therapy systems be legally marketed in the USA and elsewhere?
Vasomedical EECP therapy systems may be legally marketed in the USA, Canada, the European Union, and several other countries for use in the treatment of patients with stable or unstable angina, congestive heart failure, acute myocardial infarction, or cardiogenic shock. Information regarding a specific country may be obtained by contacting Vasomedical.